Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmaceutics ; 12(12)2020 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-33260359

RESUMO

Respiratory syncytial virus (RSV) is associated with adverse outcomes among immunocompromised patients. Inhaled ribavirin has been shown to improve mortality rates. The Small-Particle Aerosol Generator delivery system (SPAG-2) is the only FDA-cleared device to deliver inhaled ribavirin. However, it is difficult to set up and maintain. We developed a method for delivery of this medication using the vibrating mesh nebulizer (Aerogen®). We did not observe any adverse events with this method.

2.
J Pediatr Hematol Oncol ; 38(8): 597-601, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27467366

RESUMO

BACKGROUND: Children with leukemia are at risk of developing life-threatening opportunistic pulmonary infections. The role of bronchoalveolar lavage (BAL) and lung biopsy (BX) in the management of these patients is controversial. In this study, we evaluate the yield and safety of BAL and BX in children with leukemia. PROCEDURE: We reviewed the records of all children with leukemia who underwent either BAL or BX between 1997 and 2007 at the St Jude Children's Research Hospital. RESULTS: A total of 64 patients were included, of whom 35 (55%) had BX and 29 (45%) had BAL. Positive results were obtained in 69% of BAL cohort and in 46% of BX cohort. Both procedures resulted in change in antimicrobial coverage (77% in BX, 83% in BAL). Pulmonary hemorrhage occurred in 2 patients, and transient hypoxia was the most frequent complication. All resolved without negatively impacting the clinical course. CONCLUSIONS: Both BAL and BX are safe and useful in the management of children with leukemia and pulmonary disease.


Assuntos
Anti-Infecciosos/uso terapêutico , Lavagem Broncoalveolar , Leucemia/complicações , Pneumopatias/diagnóstico , Pulmão/patologia , Biópsia , Criança , Gerenciamento Clínico , Feminino , Hemorragia , Humanos , Hipóxia , Pneumopatias/complicações , Pneumopatias/tratamento farmacológico , Pneumopatias/etiologia , Masculino , Estudos Retrospectivos
3.
Jt Comm J Qual Patient Saf ; 36(1): 43-5, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20112665

RESUMO

In a clinic setting, the RRT, in conjunction with the ICU intensivist, succesfully treated a septic patient with fluid resuscitation and a vasoactive medication, and subsequently facilitated a quick transport to a higher level of care. St. Jude Children's Research Hospital's successful use of the RRT in the clinic setting suggests that RRTs can be used to improve patient outcomes across the spectrum of inpatient as well as outpatient hospital settings. Our experience suggests that RRTs can be beneficial in filling a gap in patient safety in outpatient clinics.


Assuntos
Equipe de Respostas Rápidas de Hospitais/organização & administração , Ambulatório Hospitalar/organização & administração , Taquicardia Supraventricular/terapia , Adolescente , Antiarrítmicos/uso terapêutico , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Neoplasias Ósseas/tratamento farmacológico , Flecainida/uso terapêutico , Humanos , Masculino , Sarcoma de Ewing/tratamento farmacológico , Taquicardia Supraventricular/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...